i2E & Plains Ventures Surpasses $100M Milestone in Total Investments
Innovation 2 Enterprise
NOVEMBER 21, 2024
billion at its IPO in April 2021.The The $100 million milestone was made possible through collaboration with numerous partners and stakeholders. Novazyme Pharmaceuticals Inc. was acquired by Genzyme Corp for $137.5 million in 2001. Alkami , Oklahoma’s first unicorn, was valued at $3.1
Let's personalize your content